|
Volumn 36, Issue 12 SUPPL., 1996, Pages
|
Reevaluation of some double-blind, randomized studies of dexibuprofen (seractil): A state-of-the-art overview: Studies in patients with lumbar vertebral column syndrome, rheumatoid arthritis, distortion of the ankle joint, gonarthrosis, ankylosing spondylitis, and activated coxarthrosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DEXIBUPROFEN;
IBUPROFEN;
UNCLASSIFIED DRUG;
ADULT;
ANKYLOSING SPONDYLITIS;
ARTICLE;
BIOEQUIVALENCE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEGENERATIVE DISEASE;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HIP OSTEOARTHRITIS;
HUMAN;
KNEE OSTEOARTHRITIS;
MAJOR CLINICAL STUDY;
MALE;
ORAL DRUG ADMINISTRATION;
RANDOMIZED CONTROLLED TRIAL;
RHEUMATOID ARTHRITIS;
ANKLE JOINT;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ARTHRITIS, RHEUMATOID;
DOUBLE-BLIND METHOD;
HUMANS;
IBUPROFEN;
KNEE JOINT;
LUMBAR VERTEBRAE;
OSTEOARTHRITIS, HIP;
RANDOMIZED CONTROLLED TRIALS;
SPONDYLITIS, ANKYLOSING;
STEREOISOMERISM;
|
EID: 0030452767
PISSN: 00912700
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (15)
|
References (5)
|